Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

PS: The quotes after 2018-12-03 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Gilead Sciences Static Chart

Fall of
--0.39 (+0.99%) Gilead Sciences - [Ticker: GILD]Chart Gilead Sciences  News Gilead Sciences  Download Historical Prices for Metastock Gilead Sciences and Others  Technical Analysis Gilead Sciences  
Last Trade71.55Last Trade Time2018-12-03 - 00:00:00
Variation--0.39 (+0.99%)Open72.74
Volume2,159,096Average Volume (3m)0
YieldBid / Ask74.80 x 800 - 74.82 x 1,000
Former Close71.9452 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Gilead Sciences [GILD]:   (ordered by relevance)
  1. Is Gilead Sciences Stock a Buy Now?  Motley Fool
  2. Gilead Sciences, Inc. (GILD) Stock Is Down -1.37% This Week: Buy, Hold, or Sell?  InvestorsObserver
  3. Gilead Sciences Inc. stock falls Monday, underperforms market  MarketWatch
  4. 71%of this Gilead Sciences, Inc. (NASDAQ:GILD) insider's holdings were sold in the last year  Simply Wall St
  5. Gilead Sciences Stock: Serious Trouble Is Brewing  Seeking Alpha
  1. Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials  FiercePharma
  2. Veklury antiviral coronavirus treatment vials recalled by Gilead Sciences  The Washington Post
  3. Gilead Recalls Two Lots Of Remdesivir Due To Presence Of Glass Particulates - Benzinga  Benzinga
  4. Gilead Recalls 55000 Vials of Covid Drug Due to Glass Shards  Bloomberg
  5. Gilead recalling two lots of remdesivir in the US after complaint about glass particles in the vials  Daily Mail
Gilead Sciences: Opportunity Vs. Irrelevant Value Trap  Seeking Alpha Gilead Sciences Irish pharma unit records $1.84bn loss  The Irish Times Gilead Sciences, Inc. (GILD) Management Presents At 4th Annual Evercore ISI HealthCONx Virtual Conference (Transcript)  Seeking Alpha Gilead Sciences to Present at Upcoming Investor Conference  Business Wire Gilead Sciences appoints Véronique Walsh as General Manager of UK and Ireland operations  Pharmafield Gilead Sciences Added to the Dow Jones Sustainability World Gilead Sciences (GILD) Stock Gains 20% YTD: What Lies Ahead?  Entrepreneur Gilead's Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be Highlighted With New Data at SABCS  Business Wire Gilead Sciences, Inc: An Undervalued Acquisition Machine?  Sick Economics Gilead Submits Biologics License Application to U.S. Food and Drug Administration for Bulevirtide, an Investigational Treatment for People Living With Chronic Hepatitis Delta  Business Wire Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients  Business Wire Gilead Sciences' Trodelvy marketing application OK'd in Europe for breast cancer  Seeking Alpha Gildead Sciences is Proud to be a Presenting Partner of Nati Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint  Business Wire Merck halts more trials of HIV candidate islatravir -  pharmaphorum Gilead Goes All in On Arcus Option Deal Totaling $725 Million  BioSpace Gilead to Present Data From Liver Disease Development Programs at The Liver Meeting®  Business Wire Gilead (GILD) Gets EU Nod for Breast Cancer Drug, Trodelvy  Yahoo Finance Remdesivir expected to remain effective against omicron variant, Gilead says  Fox Business The Zacks Analyst Blog Highlights: Accenture, Raytheon, Becton, Dickinson and Co, Boeing and Gilead Sciences  Yahoo Finance Transforming the South  Emory News Center Got $1,000? Check Out These 3 Top Biotech Stocks  Motley Fool GSK says its COVID antibody therapy works against Omicron. Here?s what other drugmakers say about their treatments  Fortune Monday Afternoon?s Analyst Upgrades and Downgrades: American Airlines, Biogen, Citigroup, EA, Gilead, Meta, Micron, Zscaler and More  24/7 Wall St. $39+ Billion Worldwide Checkpoint Inhibitors Industry to 2030 - Identify Growth Segments for Investment -  Yahoo Finance Project Veritas hires Washington law firm to lobby over FBI search  Reuters Amazon's (AMZN) AWS Gets Selected by Rivian, Boosts Clientele  Nasdaq Oncology Drug Developers Looking at Significant Projected Growth Through 2030 Gilead Says Co's Bold Ambition Of Transforming Triple-Negative Breast Cancer Treatment To Be Highlighted With New Data At SABCS  Benzinga Olympus Sets Sights on Growth in Its Refocused Medical Business  Yahoo Finance New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms  Yahoo Finance Former Immunomedics CFO Charged with Insider Trading  BioSpace QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND  Yahoo Finance Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA) to Advance Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders  Yahoo Finance Diversify, Diversify - Concentration Risks Of Several Pharma Companies  Seeking Alpha 21 Million in 21 years - Humana announces at the International Conference on AIDS and STIs in Africa (ICASA) that it has reached 21 Million people across the developing world in 21 years with its "Total Control of the Epidemic (TCE)" HIV/AIDS programme  Yahoo Finance PFF Summit 2021 Achieves Record Attendance, Expands New Therapies, Research and Clinical Trials  Yahoo Finance Capital Power and Enbridge Collaborate to Reduce CO2 Emissions in Alberta  Yahoo Finance Gilead Sciences wins reversal of $1.2 bln award in patent case with Bristol Myers  Reuters HCA Healthcare Invests in MEDITECH?s Web-Based Expanse Platform in New Hampshire  Yahoo Finance Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021  Business Wire LifeWorks earns prestigious endorsement from Michigan Health & Hospital Association for AbilitiCBT  Yahoo Finance Should You Buy Gilead Stock At $65?  Forbes UNC-Chapel Hill Expands Teletherapy to Better Support Student Mental Health  Yahoo Finance 12 North Carolina headquartered companies make Newsweek?s ?Most Responsible? list  WRAL Tech Wire Why Gilead Sciences Investors Shouldn't Give Up on Remdesivir Just Yet  Motley Fool Global Covid-19 cases now 265-million, Omicron spreading in the US  Business Day 3 Reasons Pfizer Stock Will Crush the Broader Market in 2022  The Motley Fool European Medicines Agency Validates Gilead's Marketing Authorization Application for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia  Business Wire Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19 | Antibodies | News Channels Gilead Sciences Might Return To The Glory Days Of Past  Seeking Alpha Global Opportunities in Drug Delivery in Cancer Market Will Grow Over USD 2262.8 Million by 2026  GlobeNewswire Gilead Sciences Q3 CAR T-Cell Therapy Sales Increase 51 Percent  Precision Oncology News CSRWire - Gilead Launches Pharmaceutical Education Program to Increase Workplace Diversity Gilead Sciences.....a Titan Reborn? | Healthcare Stocks  Sick Economics Gilead says aware of counterfeit HIV medicines being distributed in U.S.  Reuters Gilead's slumping COVID-19 drug takes another hit with study showing no real benefit  FiercePharma 'Inside the Innovation:' Oncology Leaders Discuss Life at Could Moderna Take Down Gilead Sciences?  Motley Fool Gilead shares positive findings for COVID-19 treatment Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India  Business Wire Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program  Business Wire Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021  Business Wire Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021  Business Wire Gilead Sciences: At An Inflection Point (Once Again)  Seeking Alpha Gilead: 'Cell therapy at early stages of penetration' - BioProcess Insider  BioProcess Insider Gilead to require U.S. workers receive COVID-19 vaccine  Reuters Gilead's Veklury shows 'no antiviral effects,' small WHO study says as company stands by COVID med  FiercePharma Gilead Presents Long-Term Switch Data Reinforcing Biktarvy® as a Treatment Option for a Broad Range of People Living With HIV  Business Wire Gilead Sciences considered Durham before picking Raleigh for 275-job expansion - Triangle Business Journal  Triangle Business Journal Here's the Key to Gilead Sciences' Q4 Earnings Beat  Motley Fool A Very Weird Interview With Robert F. Kennedy Jr.  Gawker Why Gilead Sciences Stock Jumped Today  Motley Fool Gilead Sciences, Inc.'s (GILD) CEO Daniel O'Day on Q3 2021 Results - Earnings Call Transcript  Seeking Alpha Gilead Sciences Seeks Approval for Twice-Annual HIV-1 Medication  BioSpace Stocks making the biggest moves after the bell: Amazon, Twitter, Gilead Sciences & more  CNBC Gilead Sciences Inc. Partners with Center for Translational Antiviral Research to Test Oral Remdesivir Variant  Georgia State University News Gilead Sciences Completes Acquisition of MYR GmbH  Business Wire Gilead Sciences Appoints Flavius Martin, MD as Executive Vice President, Research  Business Wire WHO calls for lower prices on Gilead drug for Covid-linked black fungus  Financial Times Is Gilead Sciences a Good Coronavirus Stock to Buy?  Motley Fool What Is The Ownership Structure Like For Gilead Sciences, Inc. (NASDAQ:GILD)?  Simply Wall St Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021  Business Wire Gilead to Present New Data at IAS 2021 Demonstrating the Company's Commitment to Advancing Innovation in HIV Research  Business Wire Gilead Is A Solidly Profitable, High Dividend-Yielding Stock  Seeking Alpha BioNTech to buy T-cell receptor facility and platform from Gilead Sciences  MarketWatch India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports  FiercePharma I went back into the closet at work ? until I became pregnant  PinkNews Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021  Business Wire Is Gilead Sciences, Inc. (GILD) Stock Over or Undervalued?  InvestorsObserver Where Will Gilead Sciences Be in 1 Year?  The Motley Fool Gilead CEO Got $19 Million Pay in Blockbuster Year for Company  BioSpace Gilead, Merck collaborate to develop long-acting HIV treatment  Reuters Arcus' CMO Grossman jumps ship to join Gilead's cancer push -  pharmaphorum Gilead Sciences considered Atlanta before selecting Raleigh for 275-job expansion - Atlanta Business Chronicle  Atlanta Business Chronicle Should You Be Worried About Gilead Sciences, Inc.'s (NASDAQ:GILD) 1.4% Return On Equity?  Simply Wall St Gilead (GILD) Breast Cancer Drug Gets Positive CHMP Opinion  Nasdaq
For more news about Gilead Sciences click here:
Gilead Sciences News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources